{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:25:38Z","timestamp":1777695938953,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370776"],"award-info":[{"award-number":["81370776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.therap.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T11:02:34Z","timestamp":1564138954000},"page":"261-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy"],"prefix":"10.1016","volume":"75","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2019.07.003_bib0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2017.02.010","article-title":"Significance of MDR1 gene C3435T polymorphism in predicting childhood refractory epilepsy","volume":"132","author":"Lv","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.therap.2019.07.003_bib0330","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1111\/epi.13114","article-title":"Valproate modulates glucose metabolism in patients with epilepsy after first exposure","volume":"56","author":"Rakitin","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.therap.2019.07.003_bib0335","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/seiz.2000.0432","article-title":"Characteristics of valproic acid resistant juvenile myoclonic epilepsy","volume":"9","author":"Fernando-Dongas","year":"2000","journal-title":"Seizure-Eur J Epilep"},{"key":"10.1016\/j.therap.2019.07.003_bib0340","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.yebeh.2007.12.019","article-title":"The global burden and stigma of epilepsy","volume":"12","author":"Baker","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.therap.2019.07.003_bib0345","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/jcpt.12263","article-title":"Association of ABCB1 C3435T polymorphism with phenobarbital resistance in Thai patients with epilepsy","volume":"40","author":"Keangpraphun","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.therap.2019.07.003_bib0350","doi-asserted-by":"crossref","first-page":"416","DOI":"10.31083\/ph.2015.4849","article-title":"ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population","volume":"70","author":"Zhou","year":"2015","journal-title":"Pharmazie"},{"key":"10.1016\/j.therap.2019.07.003_bib0355","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/FPC.0000000000000000","article-title":"GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures","volume":"23","author":"Balan","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.therap.2019.07.003_bib0360","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bcpt.12238","article-title":"Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanisms","volume":"115","author":"Singh","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.therap.2019.07.003_bib0365","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.24886","article-title":"Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy","volume":"81","author":"Glauser","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.therap.2019.07.003_bib0370","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.seizure.2015.05.013","article-title":"Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population","volume":"30","author":"Lv","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.therap.2019.07.003_bib0375","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007691-198903000-00002","article-title":"Urinary-excretion of valproate and some metabolites in chronically treated patients","volume":"11","author":"Dickinson","year":"1989","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.therap.2019.07.003_bib0380","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/FTD.0000000000000271","article-title":"Effects of UGT2B7 genetic polymorphisms on serum concentrations of valproic acid in Chinese children with epilepsy comedicated with lamotrigine","volume":"38","author":"Wang","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.therap.2019.07.003_bib0385","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eplepsyres.2015.04.015","article-title":"The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients","volume":"114","author":"Sun","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.therap.2019.07.003_bib0390","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2133\/dmpk.DMPK-11-NT-144","article-title":"Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy","volume":"27","author":"Guo","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.therap.2019.07.003_bib0395","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.12659\/MSM.897626","article-title":"Association of UGT2B7 and UGT1A4 polymorphisms with serum concentration of antiepileptic drugs in children","volume":"22","author":"Du","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.therap.2019.07.003_bib0400","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00228-009-0712-x","article-title":"Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling","volume":"65","author":"Jiang","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2019.07.003_bib0405","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fncel.2018.00244","article-title":"Position- and time-dependent arc expression links neuronal activity to synaptic plasticity during epileptogenesis","volume":"12","author":"Janz","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.therap.2019.07.003_bib0410","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1085\/jgp.201611721","article-title":"Calmodulin limits pathogenic Na+ channel persistent current","volume":"149","author":"Yan","year":"2017","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.therap.2019.07.003_bib0415","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2012.03474.x","article-title":"Neuronal excitability and calcium\/calmodulin-dependent protein kinase type II: Location, location, location","volume":"53","author":"Liu","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.therap.2019.07.003_bib0420","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bbadis.2015.06.012","article-title":"Epilepsy-causing mutations in Kv7.2 C-terminus affect binding and functional modulation by calmodulin","volume":"1852","author":"Ambrosino","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.therap.2019.07.003_bib0425","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1159\/000430155","article-title":"An epithelial Ca2+-sensor protein is an alternative to calmodulin to compose functional KCNQ1 channels","volume":"36","author":"Inanobe","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.therap.2019.07.003_bib0430","doi-asserted-by":"crossref","first-page":"27432","DOI":"10.1074\/jbc.M112.345108","article-title":"Glutamate binding to the GluN2B subunit controls surface trafficking of N-methyl-D-aspartate (NMDA) receptors","volume":"287","author":"She","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.therap.2019.07.003_bib0435","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.03.042","article-title":"The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia","volume":"1046","author":"M\u00f6ddel","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.therap.2019.07.003_bib0440","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.eplepsyres.2014.02.012","article-title":"Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model","volume":"108","author":"Zellinger","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.therap.2019.07.003_bib0445","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2217\/pgs.11.64","article-title":"Association of genetic variants in six candidate genes with valproic acid therapy optimization","volume":"12","author":"Hung","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.therap.2019.07.003_bib0450","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.3892\/etm.2016.3885","article-title":"Role of Wnt\/beta-catenin, Wnt\/c-Jun N-terminal kinase and Wnt\/Ca(2+) pathways in cisplatin-induced chemoresistance in ovarian cancer","volume":"12","author":"Huang","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.therap.2019.07.003_bib0455","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/138955706778993021","article-title":"Targeting calmodulin in reversing multi drug resistance in cancer cells","volume":"6","author":"Mayur","year":"2006","journal-title":"Mini Rev Med Chem"},{"issue":"7","key":"10.1016\/j.therap.2019.07.003_bib0460","doi-asserted-by":"crossref","DOI":"10.3390\/genes9070328","article-title":"Differential gene expression profile induced by valproic acid (VPA) in pediatric epileptic patients","volume":"9","author":"Floriano-Sanchez","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.therap.2019.07.003_bib0465","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eplepsyres.2017.01.011","article-title":"Prognostic factors in patients with refractory idiopathic generalized epilepsy","volume":"130","author":"Gomez-Ibanez","year":"2017","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.therap.2019.07.003_bib0470","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy. Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.therap.2019.07.003_bib0475","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.therap.2019.07.003_bib0480","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"10.1016\/j.therap.2019.07.003_bib0485","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/FTD.0000000000000337","article-title":"Effects of UGT1A6 and GABRA1 on standardized valproic acid plasma concentrations and treatment effect in children with epilepsy in China","volume":"38","author":"Feng","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.therap.2019.07.003_bib0490","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.297.5.489","article-title":"Association of genetic variations with nonfatal venous thrombosis in postmenopausal women","volume":"297","author":"Smith","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2019.07.003_bib0495","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1086\/321276","article-title":"Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer","volume":"69","author":"Ritchie","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.therap.2019.07.003_bib0500","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fncel.2014.00349","article-title":"The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication","volume":"8","author":"Ouzzine","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.therap.2019.07.003_bib0505","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200011000-00007","article-title":"Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank","volume":"10","author":"Fisher","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.therap.2019.07.003_bib0510","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00228-015-1925-9","article-title":"Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7-161C>T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children","volume":"71","author":"Liu","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2019.07.003_bib0515","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100324","article-title":"Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects","volume":"83","author":"Chung","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.therap.2019.07.003_bib0520","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.therap.2016.09.014","article-title":"Pharmacogenetics-based personalized therapy: levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx)","volume":"72","author":"Picard","year":"2017","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2019.07.003_bib0525","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00228-017-2395-z","article-title":"Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis","volume":"74","author":"Wang","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2019.07.003_bib0530","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.seizure.2009.12.004","article-title":"Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy","volume":"19","author":"Sanchez","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.therap.2019.07.003_bib0535","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.seizure.2018.04.006","article-title":"Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures","volume":"58","author":"Feng","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.therap.2019.07.003_bib0540","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-09-0494","article-title":"Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes","volume":"15","author":"Voso","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.therap.2019.07.003_bib0545","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/FTD.0000000000000012","article-title":"Influence of uridine diphosphate glucuronosyltransferase 2B7-161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients","volume":"36","author":"Inoue","year":"2014","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.therap.2019.07.003_bib0550","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/jpet.116.239707","article-title":"Regulation of UDP-glucuronosyltransferases UGT2B4 and UGT2B7 by microRNAs in liver cancer cells","volume":"361","author":"Wijayakumara","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.therap.2019.07.003_bib0555","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuroscience.2013.02.027","article-title":"Epilepsy and microRNA","volume":"238","author":"Jimenez-Mateos","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.therap.2019.07.003_bib0560","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/epi.12318","article-title":"Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains","volume":"54","author":"Ghosh","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.therap.2019.07.003_bib0565","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/epi.13703","article-title":"Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells","volume":"58","author":"Ghosh","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.therap.2019.07.003_bib0570","first-page":"42","article-title":"An association between the FABP2 gene polymorphism and efficacy of valproates","volume":"107","author":"Aksenova","year":"2007","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1016\/j.therap.2019.07.003_bib0575","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.seizure.2009.09.007","article-title":"Risk factors for valproic acid resistance in childhood absence epilepsy","volume":"18","author":"Ollivier","year":"2009","journal-title":"Seizure-Eur J Epilep"},{"key":"10.1016\/j.therap.2019.07.003_bib0580","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2605.2012.01302.x","article-title":"Novel mutations in calcium\/calmodulin-dependent protein kinase IV (CAMK4) gene in infertile men","volume":"35","author":"Khattri","year":"2012","journal-title":"Int J Androl"},{"key":"10.1016\/j.therap.2019.07.003_bib0585","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.toxlet.2009.07.016","article-title":"Lanthanum chloride impairs memory, decreases pCaMK IV, pMAPK and pCREB expression of hippocampus in rats","volume":"190","author":"Yang","year":"2009","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.therap.2019.07.003_bib0590","doi-asserted-by":"crossref","first-page":"28640","DOI":"10.1016\/S0021-9258(19)61953-8","article-title":"Activation mechanisms for Ca2+\/calmodulin-dependent protein kinase IV. Identification of a brain CaM-kinase IV kinase","volume":"269","author":"Tokumitsu","year":"1994","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.therap.2019.07.003_bib0595","doi-asserted-by":"crossref","first-page":"RC107","DOI":"10.1523\/JNEUROSCI.20-22-j0004.2000","article-title":"Cerebellar defects in Ca2+\/calmodulin kinase IV-deficient mice","volume":"20","author":"Ribar","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.therap.2019.07.003_bib0600","doi-asserted-by":"crossref","first-page":"17549","DOI":"10.1073\/pnas.0803959105","article-title":"Loss of the Ca2+\/calmodulin-dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine","volume":"105","author":"Bilbao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.therap.2019.07.003_bib0605","doi-asserted-by":"crossref","first-page":"e001081","DOI":"10.1161\/JAHA.112.001081","article-title":"CaMK4 gene deletion induces hypertension","volume":"1","author":"Santulli","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.therap.2019.07.003_bib0610","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15017207","article-title":"CAMK4 gene variation is associated with hypertension in a Uygur population","volume":"15","author":"Chen","year":"2016","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.therap.2019.07.003_bib0615","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/rej.2010.1114","article-title":"Association study on long-living individuals from Southern Italy identifies rs10491334 in the CAMKIV gene that regulates survival proteins","volume":"14","author":"Malovini","year":"2011","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.therap.2019.07.003_bib0620","first-page":"777","article-title":"Association between gene polymorphism of calcium\/calmodulin-dependent kinase 4 and efficacy of amlodipine in the treatment of hypertension in Chinese Han nationality","volume":"41","author":"Zhong","year":"2016","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.therap.2019.07.003_bib0625","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/mc.22656","article-title":"Upregulated miR-132 in Lgr5(+) gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1\/CREB\/ABCG2 signaling pathway","volume":"56","author":"Zhang","year":"2017","journal-title":"Mol Carcinog"},{"issue":"2","key":"10.1016\/j.therap.2019.07.003_bib0630","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/toxsci\/kfx093","article-title":"Insulin resistance disrupts the interaction between AKT and the NMDA receptor and the inactivation of the CaMKIV\/CREB pathway in minimal hepatic encephalopathy","volume":"159","author":"Ding","year":"2017","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.therap.2019.07.003_bib0635","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.therap.2019.07.003_bib0640","unstructured":"Broad Institute. 2019. https:\/\/pubs.broadinstitute.org\/mammals\/haploreg\/haploreg.php. [Accessed 22 July 2019]."}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719301209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719301209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:18:51Z","timestamp":1777454331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595719301209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0040595719301209"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2019.07.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}